IP Library Granted Patent US 7,683,200
Granted Patent B2
US 7,683,200 · App. 11/477,936 · Granted Mar 23, 2010

Compounds for preparing immunological adjuvant

Assignee: Eisai R & D Management Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,683,200
App. No.
11/477,936
Granted
Mar 23, 2010
Kind
B2
Abstract

The present invention provides methods for preparing TLR-4 receptor agonist E6020: and stereoisomers thereof, which compounds are useful as an immunological adjuvants when co-administered with antigens such as vaccines for bacterial and viral diseases. Also provided are synthetic intermediates.

Claims (19)

1. A compound of formula (16):

wherein:

n is 0 or 1;

R 1a is a C 1 -C 6 alkyl group, a C 3 -C 6 alkenyl group, a C 3 -C 6 alkynyl group, a phosphite oxygen protecting group, or a phosphate oxygen protecting group trimethylsilyl ether, triethylsilylether, triisopropylsilyl ether, t-butyldimethylsilyl ether, t-butyldiphenyl silyl ether, 2-trimethylsilylprop-2-enyl, 2-(trimethylsilyl)ethyl, or trimethylsilyl;

in each occurrence of R 2a and R 2c , one of R 2a and R 2c is H and the other is selected from the group consisting of tert-butyloxycarbonyl (Boc), fluorenylmethyloxycarbonyl(Fmoc), 2,2,2-trichloroethoxycarbonyl (TROC), trimethylsilylethyloxycarbonyl (TMS-ethyloxycarbonyl), cyanoethyloxycarbonyl, allyloxycarbonyl, tetrachlorophthalimide, —C(O)OR x and —C(O)CH 2 C(O)R 6 ; or R 2a and R 2c taken together are a divalent nitrogen protecting group;

R 4 is a C 5 -C 12 alkyl group or a C 5 -C 12 alkenyl group;

R 5 and R 6 are independently a C 5 -C 15 alkyl group or a C 5 -C 15 alkenyl group; and

Rx is a substituted or unsubstituted lower alkyl;

or a salt thereof.

2. A compound of claim 1 , wherein n is 1; R 4 is a C 7 alkyl; and R 5 is a C 11 alkyl.

3. A compound of claim 1 , wherein n is 1; R 1a is allyl; R 2a is hydrogen; R 2c is Boc; R 4 is a C 7 alkyl; and R 5 is a C 11 alkyl.

4. A compound of claim 3 , having the formula ER-819409:

5. A compound of claim 1 , wherein n is 1; R 2c is hydrogen; R 2c is —C(O)CH 2 C(O)R 6 ; R 4 is a C 7 alkyl; R 5 is a C 11 alkyl; and R 6 is a C 11 alkyl.

6. A compound of claim 1 , wherein n is 0; R 1a is allyl; R 2a is hydrogen; R 2c is —C(O)OR x , wherein R x is a C 1 -C 6 alkyl; R 4 is a C 7 alkyl; and R 5 is a C 11 alkyl.

7. A compound of claim 6 , having the formula ER-821843:

8. A compound of claim 1 , wherein n is 1; R 1a is allyl; R 2a is hydrogen; R 2c is —C(O)CH 2 C(O)R 6 ; R 4 is a C 7 alkyl; R 5 is a C 11 alkyl; and R 6 is a C 11 alkyl.

9. A compound of claim 8 , having the formula ER-807285:

10. The compound of claim 1 , wherein one of R 2a and R 2c is H and the other is independently selected from the group consisting of Boc, Fmoc, TROC, TMS-ethyloxycarbonyl, cyanoethyloxycarbonyl, allyloxycarbonyl, tetrachlorophthalimide, and —C(O)OR x ; or R 2a and R 2c taken together are a divalent nitrogen protecting group.

11. The compound of claim 1 , wherein one of R 2a and R 2c is H and the other is —C(O)CH 2 C(O)R 6 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2008
From: FANG, FRANCIS C.; FOY, JAMES E.; HAWKINS, LYNN; LEMELIN, CHARLES; LESCARBEAU, ANDRE; NIU, XIANG; WU, KUO-MING
To: EISAI R&D MANANGEMENT CO., LTD.
Reel/Frame 020777/0312 →
Continuity (2)
Provisional Application 6069532400 · Jun 30, 2005
Related Publication 20070082875A1 · Apr 12, 2007